Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Procaps Group ( (PROCF) ) has shared an update.
On May 8, 2025, Procaps Group appointed Carlos Garcia Iragorri and Manuel Vial as independent directors, following the resignations of Roberto Albisetti and Ernesto Carrizosa. This strategic move brings extensive experience to the board, with Mr. Garcia Iragorri’s background in pharmaceuticals and Mr. Vial’s expertise in retail and financial services, potentially strengthening the company’s market positioning and governance.
More about Procaps Group
Procaps Group, S.A. operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is based in Luxembourg and serves various markets, including Latin America and emerging markets.
Average Trading Volume: 1,781
Technical Sentiment Signal: Sell
Current Market Cap: $3.34B
Learn more about PROCF stock on TipRanks’ Stock Analysis page.